CCO Oncology Podcast
Un podcast de Clinical Care Options
Catégories:
189 Épisodes
-
Rationale for NTRK Testing in Patients With Cancer
Publié: 08/10/2021 -
Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer
Publié: 07/10/2021 -
Expert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer
Publié: 29/09/2021 -
Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma
Publié: 28/09/2021 -
Expert Insight on Practice Changing From IGCS 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
Publié: 21/09/2021 -
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
Publié: 24/08/2021 -
Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer
Publié: 19/08/2021 -
Essential Biomarker Testing in GI Cancers
Publié: 18/08/2021 -
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions
Publié: 05/08/2021 -
The Latest Advances and Guidance in Nonmetastatic Castration-Resistant Prostate Cancer
Publié: 30/07/2021 -
Managing Serious Adverse Events Associated with BTK Inhibitor Treatment
Publié: 27/07/2021 -
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 2: Patient Strategies for Self-Management
Publié: 27/07/2021 -
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions
Publié: 27/07/2021 -
BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications
Publié: 23/07/2021 -
Adverse Events Associated with BTK Inhibitor Treatment
Publié: 23/07/2021 -
Radiopharmaceuticals in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Publié: 20/07/2021 -
How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on BCMA-Targeted Therapies
Publié: 19/07/2021 -
Expert Answers to HCP Questions on CAR T-Cell Therapy
Publié: 19/07/2021 -
How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on Selinexor, Venetoclax, and Melphalan Flufenamide
Publié: 16/07/2021 -
Caring for Patients With Newly Diagnosed Multiple Myeloma
Publié: 14/07/2021
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
